EGFR expression and phosphorylation in HNSCC predict response to EGFR inhibition but cell lines are not representative for the clinical situation

被引：0
|
作者：
von Ahsen, Oliver
Khaznadar, Sami S.
Khan, Martin
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2786
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2786
引用
收藏
页数：2
相关论文
共 50 条
  • [11] EGFR Codon 497 Polymorphism - Implications for Receptor Sensitivity to Inhibitors in HNSCC Cell Lines
    Krohn, Vanessa
    Wiegand, Susanne
    Werner, Jochen A.
    Mandic, Robert
    ANTICANCER RESEARCH, 2011, 31 (01) : 59 - 65
  • [12] AKT can modulate the in vitro response of HNSCC cell to irreversible EGFR inhibitors
    Silva-Oliveira, Renato Jose
    Melendez, Matias
    Martinho, Olga
    Zanon, Maicon Fernando
    Viana, Luciano de Souza
    Carvalho, Andre Lopes
    Reis, Rui Manuel
    CANCER RESEARCH, 2017, 77
  • [13] EGFR Inhibition Using Gefitinib Is Not Active in Neuroblastoma Cell Lines
    Roessler, Jochen
    Odenthal, Eva
    Geoerger, Birgit
    Gerstenmeyer, Aurore
    Lagodny, Jeanette
    Niemeyer, Charlotte Marie
    Vassal, Gilles
    ANTICANCER RESEARCH, 2009, 29 (04) : 1327 - 1333
  • [14] Expression and activity of EGFR in human cutaneous melanoma cell lines and influence of vemurafenib on the EGFR pathway
    Alexander Gross
    Annett Niemetz-Rahn
    Anika Nonnenmacher
    Johannes Tucholski
    Ulrich Keilholz
    Alberto Fusi
    Targeted Oncology, 2015, 10 : 77 - 84
  • [15] Expression and activity of EGFR in human cutaneous melanoma cell lines and influence of vemurafenib on the EGFR pathway
    Gross, Alexander
    Niemetz-Rahn, Annett
    Nonnenmacher, Anika
    Tucholski, Johannes
    Keilholz, Ulrich
    Fusi, Alberto
    TARGETED ONCOLOGY, 2015, 10 (01) : 77 - 84
  • [16] Does EGFR expression level predict for tumor response to therapy
    Ang, K
    LUNG CANCER, 2004, 46 : S25 - S26
  • [17] EGFR and EGFRvIII Expression in Primary Breast Cancer and Cell Lines
    James M. Rae
    Joshua O. Scheys
    Kim M. Clark
    Robert B. Chadwick
    Michael C. Kiefer
    Marc E. Lippman
    Breast Cancer Research and Treatment, 2004, 87 : 87 - 95
  • [18] EGFR and EGFRvIII expression in primary breast cancer and cell lines
    Rae, JM
    Scheys, JO
    Clark, KM
    Chadwick, RB
    Kiefer, MC
    Lippman, ME
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 87 (01) : 87 - 95
  • [19] EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models
    Koi, Lydia
    Loeck, Steffen
    Linge, Annett
    Thurow, Cedric
    Hering, Sandra
    Baumann, Michael
    Krause, Mechthild
    Gurtner, Kristin
    RADIOTHERAPY AND ONCOLOGY, 2017, 124 (03) : 496 - 503
  • [20] Combined hedgehog and EGFR inhibition in pancreatic cell lines treated with gemcitabine
    Osuorji, I.
    Drelichman, A.
    Lobocki, C.
    Tilak, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345